glp-1 and ghrelin Schematic depiction of the roles of GLP1 in HG/HL-induced Effect of feeding and fasting

Patient-Centric Approach Dedicated to providing personalized treatment plans

Current evidence suggests that GLP-1 medications, when used with appropriate patient selection and monitoring, likely do not pose significant long-term threats to vision for most patients and may contribute to better overall ocular outcomes through improved metabolic control

Tongtao Yang, [email protected] These authors have contributed equally to this work Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers